Effects of dehydroepiandrosterone (DHEA) supplementation on sexual function in premenopausal infertile women
- 11 October 2018
- journal article
- research article
- Published by Springer Nature in Endocrine
- Vol. 63 (3) , 632-638
Abstract
To investigate the effects of dehydroepiandrosterone (DHEA) supplementation on female sexual function in premenopausal infertile women of advanced ages.Keywords
Funding Information
- Foundation for Reproductive Medicine (n/a)
- Center for Human Reproduction (n/a)
This publication has 35 references indexed in Scilit:
- Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR)Reproductive Biology and Endocrinology, 2011
- Is infertility a risk factor for female sexual dysfunction? A case-control studyFertility and Sterility, 2010
- Granulosa Cell-Specific Androgen Receptors Are Critical Regulators of Ovarian Development and FunctionMolecular Endocrinology, 2010
- Liquid Chromatography–Tandem Mass Spectrometry Assay for Androstenedione, Dehydroepiandrosterone, and Testosterone with Pediatric and Adult Reference IntervalsClinical Chemistry, 2010
- Sexual Problems and Distress in United States WomenObstetrics & Gynecology, 2008
- Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian functionJournal of Assisted Reproduction and Genetics, 2007
- DHEA therapy for women: effect on sexual function and wellbeingHuman Reproduction Update, 2007
- Women with low libido: correlation of decreased androgen levels with female sexual function indexInternational Journal Of Impotence Research, 2004
- Six-month oral dehydroepiandrosterone supplementation in early and late postmenopauseGynecological Endocrinology, 2000
- Dehydroepiandrosterone Replacement in Women with Adrenal InsufficiencyNew England Journal of Medicine, 1999